Article
Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
International journal of laboratory hematology - 1 Dec 2015
Arya V, Mahajan P, Saraf A, Mohanty A, Sawhney J P S, Bhargava M
Abstract excerpt
INTRODUCTION: Dual antiplatelet therapy with clopidogrel and aspirin is the current standard of care in the management of patients with coronary artery disease (CAD) and acute coronary syndrome (ACS). The variability in response to these antiplatelet agents may be due to the underlying genetic diversity. This study was designed to determine the resistance to aspirin and clopidogrel in Indian patients and to look...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
